Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual Patients

27 Oct 2020

Abstract excerpt

Pheochromocytomas and paragangliomas (PHEO/PGL) are rare but occasionally life-threatening neoplasms and all could potentially harbor malignant behavior or metastatic according to WHO classification in 2017. However, it has also been well known that histopathological risk stratification to predict the clinical outcomes has not necessarily been established. The first histopathological diagnostic algorithm of PHEO,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal and Paraganglionic Tumors
Share to Cancer, Hypoxia, and Metabolism
Share to Pituitary Gland Disorders and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33193100
DOI: 10.3389/fendo.2020.587769

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent Advances in Histopathological and Molecular Diagnosis in Pheochromocytoma and Paraganglioma: Challenges for Predicting Metastasis in Individual PatientsPMID 33193100Read ↗

Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new eraSemantic proximity Read ↗

Current Management of Pheochromocytoma/Paraganglioma: A Guide for the Practicing Clinician in the Era of Precision MedicineSemantic proximity Read ↗

The evolving roles of pathologists in paragangliomas and pheochromocytomas.Semantic proximity Read ↗

Genetics of pheochromocytoma and paraganglioma syndromes: new advances and future treatment options.Semantic proximity Read ↗

Pheochromocytoma–Paraganglioma Syndrome: A Multiform Disease with Different Genotype and Phenotype FeaturesSemantic proximity Read ↗

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task ForceSemantic proximity Read ↗

New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical ImplicationsSemantic proximity Read ↗

Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.Semantic proximity Read ↗

Pathology and genetics of phaeochromocytoma and paragangliomaSemantic proximity Read ↗

Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of OriginSemantic proximity Read ↗

Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and ParagangliomaSemantic proximity Read ↗

Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.